A Q2 2018 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$32B

Q2 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.2B+9.4% YoY

Gross Profit

$644M53.4% margin

Operating Income

$210M17.4% margin

Net Income

$205M17.0% margin

EPS (Diluted)

$0.63

QoQ Revenue Growth

-0.4%

Cash Flow

Operating Cash Flow

$303M

Free Cash Flow

$255M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$8.8B

Total Liabilities

$4.2B

Stockholders' Equity

$4.6B

Cash & Equivalents

$3.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+9.4%
Gross Profit	$644M	$592M	+8.8%
Operating Income	$210M	$201M	+4.5%
Net Income	$205M	$164M	+25.0%

Revenue Segments

Life Sciences and Applied Markets

$561M47%

Agilent CrossLab

$426M35%

Diagnostics and Genomics

$219M18%